XILIO THERAPEUTICS INC
XLO·98422T209·US·Common Stock-13D/G
XLO (XILIO THERAPEUTICS INC) is held by 11 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1M), MORGAN STANLEY ($483,516), RENAISSANCE TECHNOLOGIES LLC ($416,850). Net institutional sentiment: Bearish.
11
Holders
Avg rating(3 Elite)
$3M
Total Value
26% (23)
Fund Consensus
6 buying - 17 selling
Who's Trading
ActivistSISirenia Capital Management LP9.9%May 15, 2026
ActivistBIBCLS II Equity Opportunities, LP10.0%May 15, 2026
ActivistOAORBIMED ADVISORS LLC10.0%May 15, 2026
InsiderSSShannon James SamuelBuy $44KMar 26, 2026
ActivistSTStemPoint Capital LP8.4%Feb 17, 2026
ActivistBLBain Capital Life Sciences Fund II, L.P.1.3%Feb 17, 2026
InsiderSSShannon James SamuelBuy $17KJun 17, 2025
InsiderRRRusso ReneBuy $25KJun 16, 2025
InsiderSSShannon James SamuelBuy $31KJun 16, 2025
13F: Insider & Congress:
Showing 1-20 of 23
1 / 2
Continue exploring
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer